Outstanding international researchers have been asked to give keynote or invited lectures.
Confirmed speakers are:
Mehmet Toner, Harvard University, USA
Mehmet Toner is the Helen Andrus Benedict Professor of Biomedical Engineering at the Massachusetts General Hospital (MGH), Harvard Medical School, and Harvard-MIT Division of Health Sciences and Technology. Mehmet received a BS degree from Istanbul Technical University and an MS degree from the Massachusetts Institute of Technology (MIT), both in Mechanical Engineering. Subsequently he completed his PhD degree in Medical Engineering at Harvard-MIT Division of Health Sciences and Technology in 1989. Mehmet is the co-founding Director of the Center for Engineering in Medicine, and BioMicroElectroMechanical Systems Resource Center (BMRC) at the MGH. He is also the Director of Research at the Shriners Hospital for Children Boston. Mehmet holds over 50 patents, has more than 350 publications, and is a co-founder of multiple biotechnology start-ups. Mehmet is a “Fellow of the American Institute of Medical and Biological Engineering”, “Fellow of the American Society of Mechanical Engineers”, and “Fellow of the Society for Cryobiology.” In 2012, he was given the “Luyet Medal” by the Society for Cryobiology. In 2013, he received the “H.R. Lissner Medal” from the American Society of Mechanical Engineering. He is a member of the “National Academy of Inventors” and “National Academy of Engineers.”
Jochen Guck, TU Dresden, Germany
Dr. Guck received his PhD in Physics from the University of Texas at Austin in 2001. After being a group leader at the University of Leipzig, he moved to the Cavendish Laboratory at Cambridge University as a Lecturer in 2007 and was promoted to Reader in 2009. Since 2012 he is Professor of Cellular Machines at the Biotechnology Center of the Technische Universität Dresden. He has authored about 100 peer-reviewed publications and four patents. His work has been recognized by several awards, amongst them the Cozzarelli Award in 2008, the Paterson Prize in 2011 and an Alexander-von-Humboldt Professorship in 2012.
Mark Sutton, Public Health England, UK
Dr. Sutton graduated from the John Innes Institute with a PhD in molecular microbiology and has worked at Public Health England and its predecessors since 1997. He is currently a Scientific Leader in Healthcare Biotechnology, managing the Technology Development Group. His research interests are mainly in developing novel interventions in the field of applied decontamination science and infection control, the development and evaluation of novel antimicrobial agents and rapid detection and diagnostic systems. His group uses a variety of techniques to develop real life solutions to practical problems, working closely with end users, academic groups and commercial parties. The group takes an interdisciplinary approach, working with a variety of groups in life sciences, chemistry and physical sciences. He has authored more than 50 peer-reviewed publications and he’s a named inventor on more than 15 patent families filed internationally.
Julie Jacobson, Bill & Melinda Gates Foundation, Seattle, USA
Dr. Jacobson is a senior program officer for Infectious Diseases in the Global Health program of the Bill & Melinda Gates Foundation. She currently supports activities and investments working toward the control and elimination of neglected tropical diseases (NTDs) on the Neglected Tropical Diseases Team at the Bill & Melinda Gates Foundation. A physician with training in clinical tropical medicine and applied epidemiology, she is now the Initiative Lead for Guinea worm eradication, onchocerciasis and lymphatic filariasis elimination. She has worked on the Global Health team for over 9 years supporting research and delivery related activities and played a formative role in the development of the Neglected Tropical Diseases (NTD) Team at the foundation. She was part of the creation of the London Declaration on NTDs building a new innovative partnership to support achieving the WHO 2020 targets for ten neglected diseases and is the first and current Chair of their governing body, the Stakeholders Working Group.
Veerle Lejon, Institut de Recherche pour le Développement, Montpellier, France
Dr Lejon is research director at the Intertryp unit of the French National Research Institute for Sustainable Development (IRD) in Montpellier. Her research focuses on human African trypanosomiasis and she is member of the human African trypanosomiasis expert panel at WHO. She obtained her PhD in 2002, investigating trypanosome invasion in the brain, in search of markers for the neurological disease stage. Until 2013, she continued her research mainly at the Institute of Tropical Medicine in Antwerp, Belgium on shortened post-treatment follow-up, development of antibody detection tests including mimotope discovery and spent 1 year at McGill University in Montreal on discovery of disease markers. Dr Lejons research has always been in close collaboration with partners from endemic countries, and as a diagnostics specialist she is involved in training courses at the academic level and at the level of national control programs. Having spent time with mobile teams in disease endemic zones, she is well aware about the practical challenges faced by control programs in Africa. These form the basis of Dr Lejons actual research interests including human trypanotolerance and diagnostic algorithms adapted to an elimination context, on which she is actually coordinating an EDCTP project.
Henrik Bruus, DTU, Denmark
Prof. Bruus is head of the Section of Biophysics and Fluids and the Theoretical Microfluidics Group with a specific interest in the fundamental physics of fluids under external forcing at the micro- and nanometer scale, and performiing numerical simulations of selected systems.
Henric Bergman, National Forensic Centre, Sweden
Hamamatsu is a world leader in optoelectronics. We offer the widest product range of components, modules and systems on the market for science and research and for a broad range of applications within medicine, biotechnology, industry, automation and consumer electronics. Our worldwide organisation with headquarter in Japan has sales and technical support offices around the world. Hamamatsu Photonics Norden AB is supporting our customers in the Nordic and Baltic countries, Russia and CIS.
© Stefan Holm 2014; last updated 08 August 2017